Bjørn I. Bertelsen

1.8k total citations
31 papers, 671 citations indexed

About

Bjørn I. Bertelsen is a scholar working on Epidemiology, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Bjørn I. Bertelsen has authored 31 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Obstetrics and Gynecology and 8 papers in Molecular Biology. Recurrent topics in Bjørn I. Bertelsen's work include Endometrial and Cervical Cancer Treatments (10 papers), Cervical Cancer and HPV Research (10 papers) and Ovarian cancer diagnosis and treatment (6 papers). Bjørn I. Bertelsen is often cited by papers focused on Endometrial and Cervical Cancer Treatments (10 papers), Cervical Cancer and HPV Research (10 papers) and Ovarian cancer diagnosis and treatment (6 papers). Bjørn I. Bertelsen collaborates with scholars based in Norway, United States and Sweden. Bjørn I. Bertelsen's co-authors include Roar Sandvei, Ole Didrik Lærum, Anders Molven, Solrun J. Steine, Peer K. Lilleng, Torgils Lægreid, Inge Morild, Birger Lind, Marie Vahter and Brita Palm and has published in prestigious journals such as Annals of Neurology, Scientific Reports and American Journal of Obstetrics and Gynecology.

In The Last Decade

Bjørn I. Bertelsen

30 papers receiving 652 citations

Peers

Bjørn I. Bertelsen
Carla Janzen United States
John Ilekis United States
John E. Nichols United States
Bjørn I. Bertelsen
Citations per year, relative to Bjørn I. Bertelsen Bjørn I. Bertelsen (= 1×) peers Lino Del Pup

Countries citing papers authored by Bjørn I. Bertelsen

Since Specialization
Citations

This map shows the geographic impact of Bjørn I. Bertelsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjørn I. Bertelsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjørn I. Bertelsen more than expected).

Fields of papers citing papers by Bjørn I. Bertelsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjørn I. Bertelsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjørn I. Bertelsen. The network helps show where Bjørn I. Bertelsen may publish in the future.

Co-authorship network of co-authors of Bjørn I. Bertelsen

This figure shows the co-authorship network connecting the top 25 collaborators of Bjørn I. Bertelsen. A scholar is included among the top collaborators of Bjørn I. Bertelsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjørn I. Bertelsen. Bjørn I. Bertelsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagner‐Larsen, Kari S., Erlend Hodneland, Kristine E. Fasmer, et al.. (2025). MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer. BMC Cancer. 25(1). 122–122.
2.
Wagner‐Larsen, Kari S., Kristine E. Fasmer, Mari K. Halle, et al.. (2025). Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer. Cancer Imaging. 25(1). 23–23. 1 indexed citations
3.
Halle, Mari K., Hege F. Berg, Kathrine Woie, et al.. (2024). 24MO TROP-2, TF and NECTIN4 as targets for ADC treatment in cervical cancer. ESMO Open. 9. 103524–103524. 1 indexed citations
4.
Berg, Hege F., Tomasz Stokowy, Erling A. Høivik, et al.. (2024). Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. International Journal of Gynecological Cancer. 34(7). 993–1000. 1 indexed citations
5.
Halle, Mari K., Erlend Hodneland, Kari S. Wagner‐Larsen, et al.. (2024). Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer. Scientific Reports. 14(1). 11339–11339. 2 indexed citations
6.
Halle, Mari K., Kari S. Wagner‐Larsen, Kathrine Woie, et al.. (2023). Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer. Gynecologic Oncology. 181. 110–117. 1 indexed citations
7.
Wagner‐Larsen, Kari S., Erlend Hodneland, Kristine E. Fasmer, et al.. (2023). MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer. Cancer Medicine. 12(20). 20251–20265. 7 indexed citations
8.
Wagner‐Larsen, Kari S., Jone Trovik, Mari K. Halle, et al.. (2022). What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?. Insights into Imaging. 13(1). 105–105. 10 indexed citations
9.
Halle, Mari K., Kathrine Woie, Kari S. Wagner‐Larsen, et al.. (2021). A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. British Journal of Cancer. 124(10). 1690–1698. 22 indexed citations
10.
Halle, Mari K., Aishwarya Sundaresan, Jianqing Zhang, et al.. (2021). Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma. npj Genomic Medicine. 6(1). 82–82. 15 indexed citations
11.
Wallin, Keng‐Ling, Marit Valla, Anna Måsbäck, et al.. (2017). A Selective Biomarker Panel Increases the Reproducibility and the Accuracy in Endometrial Biopsy Diagnosis. International Journal of Gynecological Pathology. 36(4). 339–347. 6 indexed citations
12.
Halle, Mari K., Akinyemi I. Ojesina, Kathrine Woie, et al.. (2017). Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. American Journal of Obstetrics and Gynecology. 217(4). 432.e1–432.e17. 40 indexed citations
13.
Flaatten, Hans, Guttorm Brattebø, B. Almé, et al.. (2017). Adverse events and in-hospital mortality: an analysis of all deaths in a Norwegian health trust during 2011. BMC Health Services Research. 17(1). 465–465. 15 indexed citations
14.
Köbel, Martin, Bjørn I. Bertelsen, Olli Carpén, et al.. (2013). Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry. Histopathology. 64(7). 1004–1013. 82 indexed citations
15.
Bertelsen, Bjørn I., et al.. (2007). Færre sykehusobduksjoner – lang svartid. Tidsskrift for Den Norske Laegeforening. 2 indexed citations
16.
Björkman, Lars, Torgils Lægreid, Bjørn I. Bertelsen, et al.. (2007). Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study. Environmental Health. 6(1). 30–30. 165 indexed citations
17.
Bertelsen, Bjørn I., et al.. (2006). HPV subtypes in cervical cancer biopsies between 1930and 2004: detection using general primer pair PCR and sequencing. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 449(2). 141–147. 18 indexed citations
18.
Lærum, Ole Didrik, et al.. (2003). Arkivpatologi – nye perspektiver på lagret vevsmateriale. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
19.
Ibrahim, Salah O., Bjørn I. Bertelsen, May Britt Kalvenes, et al.. (1998). Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: Lack of association with human papillomavirus infection. Apmis. 106(7-12). 959–969. 26 indexed citations
20.
Bertelsen, Bjørn I. & F Hartveit. (1995). The cervical smear record: Its relevance to the subsequent development of cervical neoplasia. Acta Obstetricia Et Gynecologica Scandinavica. 74(9). 729–733. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026